Industry Experts - Market Research

Asia-Pacific Leads Global Atrial Fibrillation Market to Witness Robust 13% CAGR and to Reach $32 billion by 2027 – Market Research Report (2022-2027) by Industry Experts, Inc.

Monday 02 May 2022

Industry Experts, Inc. published the new market research report "Global Atrial Fibrillation Market – Treatment Types and End-User Facilities". As per the new report, Non-Pharmacological Treatment is estimated the largest type for Atrial Fibrillation treatment accounting for about 59% market in 2021 while the same is projected to grow by the fastest CAGR of 13.6% during the period 2022-2027.

Atrial Fibrillation (AF) is the most common arrhythmia, which can lead to stroke, peripheral embolization, heart failure and other unfavorable outcomes. While the incidence of AF among the general population has been found to be at about 2.3%-3.4%, this registers a significant increase in patients with pulmonary disease, critical illness or systemic inflammatory response syndrome, with devastating clinical impact. A number of recent epidemiological studies have established a greater risk of AF and new-onset AF among patients with COVID-19, though the results have been quite inconsistent. The literature available thus far has indicated that AF or new-onset AF can have a substantial association with the worst outcomes, viz., mortality, in patients with COVID-19.

Apart from the recent development of COVID-19 and its effect on AF, other factors that increase the risk of this condition include growing worldwide prevalence of obesity and heart diseases. The rise in the number of AF cases is fueling the market for treating this disease, though at the same time posing a crushing burden on the economies of several countries because of the high treatment cost involved.

The market for Atrial Fibrillation treatment types/sub-types analyzed in this report includes Non-Pharmacological – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments; Pharmacological – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs. The study also explores the market for end-user facilities of Atrial Fibrillation treatment include Ambulatory Surgical Centers, Cardiac Centers and Hospitals.

This report reviews, analyzes and projects the Atrial Fibrillation market for global and the regional markets including the North America, Europe, Asia-Pacific and Rest of World for the period 2018-2027 in terms of value in USD. These regional markets further analyzed for 10 independent countries across North America – the United States, Canada and Mexico; Europe – France, Germany, Italy and the United Kingdom; Asia-Pacific – China, India and Japan. The market is analyzed in each region by key country, treatment type/sub-type and by end-use facility.

This 246 page report on Atrial Fibrillation market includes 194 charts (includes a data table and graphical representation for each chart), supported with a meaningful and easy to understand graphical presentation, of the market. The statistical tables represent the data for the global market by geographic region, treatment type and end-user facility. This study profiles 14 key global players and 19 major players across the North America – 10; Europe – 6; and Asia-Pacific – 3. The report also provides the listing of the companies engaged in research & development, manufacturing, supply of atrial fibrillation. The global list of companies covers addresses, contact numbers and the website addresses of 70 companies.

California, USA based Industry Experts, Inc. is a multi-industry focused market research provider.

For more details, please visit: https://industry-experts.com/verticals/healthcare-and-pharma/global-atrial-fibrillation-treatment-market